Chitosan/Sodium Tripolyphosphate Microemulsion Enhanced Oral Insulin Delivery via Intestinal Lymphoid
Macromolecular Bioscience · 2025-04 · 25 (4)
DOI: 10.1002/mabi.202400520 ↗Kurz gefasst
Fachartikel in der Zeitschrift Macromolecular Bioscience, online erschienen am 27.02.2025. Verfasst von Zhengpeng Zhong und 5 weiteren Autor:innen. Beteiligte Einrichtung: School of Pharmacy and Bioengineering, Chongqing University of Technology, 69 Hongguang Avenue, Chongqing, 400054, China. Hauptthemen laut MEDLINE: Chitosan, Insulin, Diabetes Mellitus, Experimental, Drug Delivery Systems. Die Arbeit wurde bisher 5-mal zitiert (Crossref) und nennt 38 Literaturangaben. Gefördert von: Natural Science Foundation of Chongqing, Natural Science Foundation of Chongqing Municipality.
Abstract (Originalsprache)
Oral insulin delivery systems are currently being explored as the best alternative to subcutaneous injections, aiming to overcome gastrointestinal barriers and achieve efficient oral insulin delivery. This study presents a microemulsion delivery system that utilizes chitosan/sodium tripolyphosphate (CS/STPP) to enhance the stability of kernel‐loaded insulin and increase bioavailability via intestinal absorption and lymphatic transport. The insulin/chitosan/sodium tripolyphosphate‐microemulsion (Ins/CS/STPP‐ME) is a particle size of (81.03 ± 7.19) nm and a polydispersity index (PDI) of (0.313 ± 0.013). Infrared spectroscopy confirms insulin encapsulation. Ins/CS/STPP‐ME exhibits favorable stability and releasesproperties in gastrointestinal fluids, retaining a maximum of (53.076 ± 12.587)% insulin in a pepsin environment and (62.982 ± 13.105)% in a trypsin environment after 60 min. In vivo studies have demonstrated that the addition of CS/STPP to the internal phase of Ins/CS/STPP‐ME results in a rapid onset of action and sustained hypoglycaemic effect in diabetic rats. Lymphatic blockade by cycloheximide verified Ins/CS/STPP‐ME and its ability to cross the gut and enter the bloodstream via lymphatic transport. This work demonstrates that Ins/CS/STPP‐ME can stabilize proteins in the gastrointestinal environment, facilitate lymphatic absorption, enhance bioavailability, and provide longer‐lasting hypoglycemic effects, thus providing the possibility for oral biomacromolecule delivery.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- School of Pharmacy and Bioengineering, Chongqing University of Technology, 69 Hongguang Avenue, Chongqing, 400054, China.
- The Center Affiliated Hospital of Chongqing University of Technology, Intersection of Lishi Road and Mawangping Main Street, Banan District, Chongqing, 400054, China.
ORCID-Profile: Fuping Wang
Förderung
- Natural Science Foundation of Chongqing
- Natural Science Foundation of Chongqing Municipality
Zitieren
APA
Zhong, Z., Wang, F., Gong, X., Hu, C., Chen, G., & Chen, Z. (2025). Chitosan/Sodium Tripolyphosphate Microemulsion Enhanced Oral Insulin Delivery via Intestinal Lymphoid. Macromolecular Bioscience, 25(4). https://doi.org/10.1002/mabi.202400520
Vancouver
Zhong Z, Wang F, Gong X, Hu C, Chen G, Chen Z. Chitosan/Sodium Tripolyphosphate Microemulsion Enhanced Oral Insulin Delivery via Intestinal Lymphoid. Macromolecular Bioscience. 2025;25(4). doi:10.1002/mabi.202400520
BibTeX
@article{Zhong2025,
author = {Zhong, Zhengpeng and Wang, Fuping and Gong, Xue and Hu, Changfu and Chen, Guobao and Chen, Zhongmin},
title = {Chitosan/Sodium Tripolyphosphate Microemulsion Enhanced Oral Insulin Delivery via Intestinal Lymphoid},
journal = {Macromolecular Bioscience},
year = {2025},
volume = {25},
number = {4},
doi = {10.1002/mabi.202400520}
}
EUVIMED